Resources

Smart contact lenses are capable of tracking tear glucose levels and delivering drug therapy directly to the retina.

Prediabetes has been linked as a risk factor to developing type 2 diabetes over the years, but limited data is available in older adults.

By Sheri Colberg, PhD
Glucagon is such an important hormone when it comes to blood glucose management in everyone—and it both impacts and is impacted by type 1 diabetes (T1D). A recent mini-review in Physiological Reports focused on altered glucagon responses brought up some interesting points that are worth discussing further.

Cardiovascular and renal disease burdens also occur in type 1 diabetes.

Maintaining proper skincare can help in preventing infections when using diabetes devices.

When metformin therapy fails in youth, alternatives are limited to human insulin and liraglutide.

Patients who have obesity but don't have diabetes may now reap the benefits of using a GLP-1 receptor agonist.

Medtronic recently announced the launch of its new extended infusion set.

A woman, 72 years of age, type 2 diabetes, obesity, taking metformin, GLP1, ARB, and antidepressant (SSRI). Lost 20% total body weight in the past year. Recently complaining of dizziness and weakness. Glucose levels in the 60’s at home, at which time had symptoms of hypoglycemia. Glucose-lowering medications (metformin and GLP-1) were stopped. Continued to complain of dizziness and weakness especially in the morning.

Can variability in HbA1c lead to a higher risk of mortality in persons with diabetes?